MedPath

The Effect of Different Ketone Supplements on β-OHB and Blood Glucose in Healthy Individuals

Not Applicable
Completed
Conditions
Blood Glucose
Ketosis
Interventions
Dietary Supplement: 1,3-Butanediol
Dietary Supplement: (R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester
Dietary Supplement: Beta-hydroxybutyric acid
Registration Number
NCT05273411
Lead Sponsor
University of British Columbia
Brief Summary

Ketone bodies are a fuel source and signaling molecule that are produced by your body during prolonged fasting or if you consistently eat at low-carbohydrate diet. Blood ketones can be used as a source of energy during fasting and are used by your brain as an alternative source of fuel to glucose. Previous studies have found that ketones, when consumed in form of a supplement drink, can increase blood ketone levels and lower blood glucose, the amount of sugar in your blood. This is of potential interest for individuals with high blood sugar, such as people living with type 2 diabetes. However, there are different types of ketone supplements that differ in how they are metabolized in the body. Little is known about how these supplements affect blood ketone and blood glucose levels. The main objective of this study is to determine the effect of three different ketone supplements on blood ketones and blood glucose. The results of this pilot study will be used to guide future research for larger and more extensive studies on ketone supplements.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • over the age of 18;
  • able to fast overnight
Exclusion Criteria
  • being a competitive endurance athlete;
  • following a ketogenic diet, low-calorie diet, periodic fasting regimen, or regularly consuming ketogenic supplements;
  • being unable to travel to and from the university;
  • being unable to follow the diet instructions;
  • being pregnant or planning to become pregnant during the study;
  • having been diagnosed with a chronic disorder of glucose or fat metabolism, including type 2 diabetes, chronic pancreatitis, or gallbladder disease;
  • being unable to read or communicate in English

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
1,3-Butanediol1,3-Butanediol1 x 35 mL
(R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester(R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester1 x 20 mL
Beta-hydroxybutyric acidBeta-hydroxybutyric acid1 x 237 mL
Primary Outcome Measures
NameTimeMethod
Blood Beta-hydroxybutyrate240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation)

Are under the curve (AUC) across 240 minutes after supplement consumption (assessed at baseline and 15, 30, 60, 90, 120, 180, and 240 post-supplementation)

Secondary Outcome Measures
NameTimeMethod
Blood Pressure240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation)

Change over time

Supplement Acceptability & Taste240 minutes post-supplementation

Questionnaire

Gastrointestinal Discomfort60 minutes post-supplementation

Questionnaire

Blood Glucose240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation)

Area under the curve (AUC)

Heart Rate240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation)

Change over time

Hunger & Fullness240 minutes post-supplementation

Questionnaire

Trial Locations

Locations (1)

University of British Columbia Okanagan

🇨🇦

Kelowna, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath